Vivian E. Drory - Concepedia

Author

Vivian E. Drory

Also Known As

Drory, Vivian, Drory, Vivian E., Ian P. Blair, Jan Veldink, Leonard H. van den Berg, Lorne Zinman, Lucie Bruijn, Mamede de Carvalho, Russell McLaughlin, Steven Finkbeiner

171

Publications

10.4K

Citations

H-Index

146

Concepts

All Affiliations

Tel Aviv Sourasky Medical Center Tel Aviv University University of Milan University College London University Medical Center Utrecht

About

Vivian E. Drory is an author at Tel Aviv Sourasky Medical Center specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	48	4.1K
2	Health Sciences	12	12	656
3	Social Sciences	4	4	162
4	Engineering	1	1	33
5	Public Health	1	1	73

Vivian E. Drory

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study Elisa Majounie, Alan E. Renton, Kin Y. Mok, The Lancet Neurology Neurodegenerative DiseasesAmyotrophic Lateral SclerosisDementiaFrontotemporal DementiaNeuroscience	2012	1.2K
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis Chi-Hong Wu, Claudia Fallini, Nicola Ticozzi, Nature Neurodegenerative DiseasesAmyotrophic Lateral SclerosisDevelopmental BiologyProfilin 1Genetic Disorder	2012	594
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A Anna‐Leigh Brown, Oscar G. Wilkins, Matthew J. Keuss, Nature	2022	471
The value of muscle exercise in patients with amyotrophic lateral sclerosis Vivian E. Drory, Evgeny Goltsman, Jacqueline Reznik, Journal of the Neurological Sciences Amyotrophic Lateral SclerosisMotor DysfunctionKinesiologyNeurological DisorderExercise	2001	281
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial Ivo N. van Schaik, Vera Bril, Nan van Geloven, The Lancet Neurology Subcutaneous ImmunoglobulinAutoimmune DiseaseChronic InflammatoryMaintenance TreatmentImmunotherapy	2017	258
Laser Phototherapy (780 nm), a New Modality in Treatment of Long-Term Incomplete Peripheral Nerve Injury: A Randomized Double-Blind Placebo-Controlled Study Shimon Rochkind, Vivian E. Drory, Malvina Alon, Photomedicine and Laser Surgery	2007	167
Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress? Daniel Keizman, Maya Ish‐Shalom, Shlomo Berliner, Journal of the Neurological Sciences Electrolyte DisorderAmyotrophic Lateral SclerosisPhysiologyNeurologyMedicine	2009	138
Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? Nachum Vaisman, Michal Lusaus, Beatrice Nefussy, Journal of the Neurological Sciences Neurodegenerative DiseasesAmyotrophic Lateral SclerosisMotor DysfunctionNeurological DisorderEnergy Needs	2009	116
Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis Daniel Keizman, Ori Rogowski, Shlomo Berliner, Acta Neurologica Scandinavica	2009	109
Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis Vivian E. Drory, Miriam Birnbaum, Amos D. Korczyn, Journal of the Neurological Sciences Neurodegenerative DiseasesAmyotrophic Lateral SclerosisNeurological DisorderApoe ε4 AllelePathology	2001	97

Page 1